In accord with a set of prespecified principles of cell synchrony induction, a three-step procedure was developed to arrest cells reversibly in the G2 phase of the cell cycle. Cultures of Chinese hamster ovary (CHO) cells were presynchronized in early S phase by sequential treatment with isoleucine deficiency and hydroxyurea blockades; then they were switched to medium supplemented with either of two agents that inhibit DNA topoisomerase II activity by different mechanisms, Hoechst 33342 at 7.5 ,Lg/ml for 12 hr or VM-26 at 0.5 ,gg/ml for 8 hr. Up to 95% of the cells accumulated in G2 phase under those conditions. After switch of Hoechst 33342-treated cells to drug-free medium, the cells divided as a highly synchronized cohort of cells within 3 hr. Up to 85% of the cells in a culture of human diploid dermal fibroblasts (HSF-55 cells) could be accumulated in G2 phase by placing cells presynchronized in early-S phase in medium containing Hoechst 33342 at 0.1 jug/ml for 10 hr. Reversal of G2 arrest in the HSF-55 cultures resulted in cells dividing sychronously over 3.5 hr. By varying the concentration of Hoechst 33342 and the duration of the treatment period, it was possible to alter the position within G2 phase at which cells accumulated. This synchronization protocol should greatly facilitate study of G2/M biochemical events in mammalian cells, in particular, those associated with cdc2 gene regulation of the onset of mitosis.
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Studies of events within the mammalian cell cycle are greatly facilitated by the use of highly synchronized populations in which all or most cells perform the same biochemical operations simultaneously. Among factors to be considered when using or developing a synchronization protocol are the following: (i) avoidance of conditions that force cells into a state of "biochemical imbalance" (1) in which the ratios of major macromolecules are grossly perturbed; (ii) assurance that the synchronization protocol is completely reversible; and (iii) recognition that the synchrony is rapidly lost (2, 3) to the extent that no single synchronization protocol is suitable for study of events throughout the entire cell cycle.
In this manuscript, these principles of synchrony induction have been applied to the development of a protocol to arrest mammalian cells reversibly in G2 phase. The need for such populations stems from the recent rekindling of interest in studies of the cell cycle, attributable to the development of techniques for elucidating the mechanisms responsible for genetic regulation of cell proliferation. In particular, studies with a variety of biological systems, predominantly involving the lower eukaryotes, have revealed the existence of a series of cdc2-like genes shown to play a crucial role in regulating the initiation of mitosis (4) (5) (6) (7) (8) (9) (10) (11) . These studies are currently focusing on the molecular interactions between the proteins encoded by the cdc2 gene and cellular constituents that trigger the transition from G2 phase into mitosis.
Such studies previously were difficult to do with mammalian cells due to the lack of a system in which essentially all cells would progress from G2 phase into mitosis in highly synchronous fashion. Earlier-derived procedures for accumulating mammalian cells in G2 phase through use of centrifugal elutriation (9, 12) or temperature-sensitive mutants (13) produced populations in which only 60-70%o of the cells resided in G2 and the cells were slow to recover from the effects of the synchrony-induction method.
Our G2 synchronization protocol overcomes the shortcomings of these previous procedures. Cells, presynchronized in early S phase, are treated with low doses of either of two different inhibitors of DNA topoisomerase II (Top II) activity, which causes cells to progress slowly through late interphase as a highly synchronized cohort of cells. Up to 95% of the cells can be accumulated in G2 phase with our procedure and after inhibitor removal, the cells divide in a highly synchronous manner within 3-3.5 hr.
MATERIALS AND METHODS
Cell Growth. Chinese hamster ovary (CHO) cells maintained as either monolayers in 75-cm2 tissue culture flasks or in suspension in 250-ml spinner flasks, were grown in F-10 medium supplemented with 15% heat-inactivated (560C for 30 min) bovine calf serum (HyClone) and antibiotics (F10/15C); the CaCl2 component of F-10 was omitted in studies involving suspension cultures. Plating efficiency measurements of colony-forming ability were made in a described manner (14) , with cells plated immediately after reversal of the final synchrony-inducing blockade. HSF-55 diploid fibroblasts, derived by D. Chen (Los Alamos National Laboratory) from a human neonate foreskin sample, were grown as monolayers in 75-cm2 tissue culture flasks in a minimum essential medium supplemented with 10o heat-inactivated bovine calf serum and antibiotics (aMEM/lOC). Flow-cytometric analysis of DNA content in mithramycin-stained cells was done as described (15 (18) , after which the monolayers were exposed to aMEM/lOC containing aphidicolin at 5 ttg/ml for 24 hr to arrest the cells in very-early-S phase (18) . The (20, 25) . In preliminary studies with CHO cells employing flow cytometry to monitor DNA distributions, it was determined that: (i) treatment of asynchronous populations with Hoechst 33342 produced an enrichment of cells in G2 phase, but the effects were not readily reversible; (ii) treatment of cells presynchronized in early-S phase with Hoechst 33342 during progression through late interphase caused cells to arrest reversibly in G2; and (iii) accumulation of cells in G2 phase was greatest when Hoechst 33342 was added when the cells were in very-early-S phase. Optimum results were achieved in monolayer cultures of cells presynchronized in early-S phase by sequential incubation in isoleucine-deficient medium and then medium containing hydroxyurea (16, 17) , after which the cells were maintained for 12 hr in complete medium containing Hoechst 33342 at 7.5 ,ug/ml equivalent to 13 ,uM (Fig. 1) .
The fraction of cells residing in G2 phase in the culture shown in Fig. 1 (Fig. 2) . Examination of the data in Fig. 2 Fig. 1 , and at t = 0 hr, the cultures were washed and placed in complete, Hoechst 33342-free F-10 medium. At intervals thereafter, cultures were trypsinized, and aliquots were removed to obtain population DNA distributions via flow cytometric analysis of mithramycin-stained cells (A) and cell counts (B). In this instance, TD is arbitrarily defined as the time required for all cells in the population to divide if they all divide at the rate characteristic of the highly synchronized, majority cohort of cells.
mented with aphidicolin (18) . After additional exposure to medium containing 0.17 ,uM Hoechst 33342 at 0.1 ,ug/ml for 10 hr, populations containing 80-85% G2 cells were obtained (0-hr sample in Fig. 3 ). Cells began entering G1 phase within 1 hr after Hoechst 33342 removal (indicating that the cells were located in the late-G2 phase, as desired), and they divided as a highly synchronized cohort over a 3.5-hr period.
A study similar in design to that shown in Fig. 3 was also done with mithramycin, an agent that, like Hoechst 33342, binds in the minor groove of DNA, but unlike Hoechst 33342, exhibits affinity for G+C-rich regions ofDNA (30 (25, 31, 32) . Greater than 95% of the cells accumulated in G2 phase after treatment of early-S-phase-presynchronized cells with VM-26 at 0.5 ,Ug/ ml for 8 hr (0-hr sample in Fig. 4 ). After removal of the VM-26, the cells began dividing after an initial delay of 4 hr, indicating that VM-26 can also induce a reversible state of G2 arrest.
DISCUSSION
The success obtained with two very different cell types confirms the validity of use of multiple cell-progressioninterrupting procedures to achieve highly synchronized populations in G2 phase. Interference with Top II activity appears an important component ofour protocol because highly enriched G2 populations were obtained with two inhibitors of Top II, differing in their mechanism of interference with this DNA conformation-altering enzyme. Because the effects of Hoechst 33342 were found to be more readily reversible (Fig.  2 ) than those associated with exposure to VM-26 (Fig. 4) , we recommend Hoechst 33342 as the synchrony-induction agent of choice. Because the optimum concentration of Hoechst 33342 was 75-fold greater in CHO cells (Fig. 1) than in HSF-55 cells (Fig. 3) , optimum conditions will need to be established for each new cell type to be studied; however, we suspect that most cells will require very low levels ofHoechst 33342 (0.1-0.2 ,ug/ml) added in very-early-S phase for optimal induction of G2 synchrony. We also suspect that agents such as distamycin, DAPI [(4',6-diamidino-2-phenylindole)-dihydrochloride], netropsin, and berenil, which interact with DNA similarly to that of Hoechst 33342 (19, 26) through both an alteration in the extent of relaxation in the region of the genome to be transcribed and through interference with the interaction between RNA polymerase and the DNA (33) . Partial inhibition of relaxation of DNA should result in a decreased rate of DNA replication that would slow down the rate of progression through S phase, whereas partial inhibition of transcription would be expected to cause cells to progress slowly through both S and G2 phases because transcriptive activity appears to be required through- out both these phases of the cell cycle (34) . In contrast, prevention of Top II-mediated decatenation reactions should result in a reduced ability to disentangle sister chromatids (20, 21) , which would prevent cells from initiating mitosis.
We observed a general slowdown in rate of progression of cells through both S and G2 phases in Hoechst 33342-treated cultures [12 hr required for optimal accumulation of CHO cells in G2 in Hoechst 33342-treated cultures (Figs. 1 and 2 ) versus 6 hr to achieve the maximum fraction of G2 cells in drug-free cultures (data not shown)]. These results may indicate that the inhibitory effects of Hoechst 33342 were directed primarily against DNA relaxation and transcriptive events. In addition to its effects on Top II activity, binding of Hoechst 33342 to DNA might also induce a steric impediment to packaging of DNA, which would be reflected as an alteration in the chromatin-condensation cycle as cells progress through the division cycle (35) (36) (37) (38) (39) (40) .
In contrast to Hoechst 33342 effects, CHO cells exposed to VM-26 traversed S and G2 phases at a nearly normal rate of progression [requiring only 8 hr to attain a maximum fraction of G2 cells (Fig. 4) ], but they were delayed from entering mitosis for a period of 4 hr after VM-26 removal. These results may indicate that the primary effect of VM-26 under our culture conditions was interference with Top II-catalyzed decatenation reactions. In agreement with that suggestion was an observed accumulation of preprophase-like cells with partially condensed chromosomes during the 4-hr period between VM-26 removal and resumption of cell division.
Regardless ofthe nature ofthe underlying mechanisms, our protocols should provide an important tool for examining, in mammalian cells, the biochemical events associated with passage of cells through G2 phase and into mitosis. An important property of our protocol is the capability to preselect both the precise location of the arrest point in G2 phase and the rate of progression of cells across the G2/M boundary. This capability, in turn, should permit the most detailed studies to date of the sequence of events associated with activation of the cdc2-encoded protein kinase at G2/M and subsequent phosphorylation of cellular proteins required for initiation of mitosis. The production of populations initiating mitosis with a high degree of synchrony available with our protocol may also find application in the high-resolution cytogenetics' studies of Yunis et al. (41, 42) , in which thousands of G-bands can be characterized in haploid sets of chromosomes from cells synchronized in mid-prophase. Finally, application of these principles of synchronization to phases of the cell cycle other than G2 may provide an improved quality of synchrony for them as well.
